2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
The University of Arizona Cancer Center has been an NCI Designated Comprehensive Cancer Center for more than three decades, and is the only NCI Designated Comprehensive Cancer Center headquartered in the State of Arizona. The Cancer Center is uniquely poised to serve the needs of its diverse catchment area and address health disparities throughout the United States. UACC is leading the way by fostering innovation in collaborative research and cancer care.
July 04, 2023
Video
Christian Marth, MD, PhD, reviews the adverse effects of pembrolizumab and lenvatinib in the treatment of endometrial cancer, as well as the patient experience with these treatments.
July 04, 2023
Video
Bradley J. Monk, MD, FACS, FACOG, and Christian Marth, MD, PhD, share treatment approaches to patients with endometrial cancer with a low response rate to chemotherapy, highlighting a biomarker-based approach.
June 27, 2023
Video
Christian Marth, MD, PhD, and Bradley J. Monk, MD, FACS, FACOG, discuss data from the NRG GY018 and RUBY trials regarding the use of immunotherapies for the treatment of endometrial cancer.
June 20, 2023
Video
Bradley J. Monk, MD, FACS, FACOG, reviews the available chemotherapy options for treating advanced and recurrent endometrial cancer, as well as compares notes with Christian Marth, MD, PhD, on his clinical experience.
June 20, 2023
Video
Christian Marth, MD, PhD, discusses the prevalence of endometrial cancer, as well as the steps that lead to diagnosis.
May 30, 2023
Video
Comprehensive insights on unmet needs, ongoing research, and the future of advanced ovarian cancer treatment.
May 30, 2023
Video
Expert oncologists review the current PARP inhibitor treatment indications for patients with advanced ovarian cancer and discuss how to best manage patients who have been impacted by the recent updates to the PARP inhibitors.
May 30, 2023
Video
Drs Coleman and Monk discuss what led to the recent withdrawal of several indications for PARP inhibitors in the treatment of advanced ovarian cancer.
May 30, 2023
Video
Expert oncologists give an overview of PARP inhibitors available for the treatment of patients with advanced ovarian cancer and review adverse events seen with each agent.
May 30, 2023
Video
Experts on advanced ovarian cancer give detailed insights on the role of biomarker testing and identify important biomarkers.
May 30, 2023
Video
Robert L Coleman, MD, FACOG, FACS, and Bradley J Monk, MD, FACOG, FACS, provide an overview of advanced ovarian cancer and discuss its prevalence and diagnosis process.
March 27, 2023
Article
A University of Arizona project, with funding from the state's New Economy Initiative, creates humanlike cancer models and growth environments to help improve prevention, diagnosis and treatment.
March 20, 2023
Article
Jennifer Hatcher, PhD, RN, MPH, has been appointed as associate director of Inclusivity, Diversity, Equity and Accessibility for the University of Arizona Cancer Center.